2 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 2, Unknown 1 |
Follow bamlanivimab: new trials by email Literature Review of bamlanivimab trials Research Report on bamlanivimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19 Bamlanivimab, Standard of Care - Covid19 | Phase 4 | Unknown | Fraser Health | 576 | 2021-03-17 | 2021-08-26 |
| Treatment of Nosocomial COVID-19 Anti-SARS-CoV-2 mAb - Covid19, Nosocomial Infection | Phase 4 | Terminated | University of Calgary | 46 | 2021-02-12 | 2023-04-19 |
| At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 bamlanivimab - Covid19 | Phase 4 | Terminated | Daniel Griffin | 139 | 2021-01-04 | 2022-03-18 |
COVID-19 (3) · Cross Infection (1)
Daniel Griffin (1) · Fraser Health (1) · University of Calgary (1)
Canada (2) · United States (1)
Alain Tremblay (1) · Dan Griffin, MD, PHD (1) · Robert Fowler (1) · Srinivas Murthy (1)